New treatment approach shows promise in reducing prostate cancer spread
Adding darolutamide to standard treatment for aggressive prostate cancer reduced the risk of the disease spreading in an international phase 3 trial.
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
One violin lesson changes brain wave patterns as beginners learn to play
United Kingdom
-
UCL scientists design symbolic AI digital twins to treat cancer
United Kingdom
-
Watching others face danger may shape how we learn, rat experiments suggest
United Kingdom
-
Proteins linked to Alzheimer's found to assist sperm cells
United Kingdom
-
Implantable drug-delivery device could help prevent recurrence of glioblastoma
United Kingdom
-
African health experts urge immediate action over new Ebola cases
United Kingdom
-
Friends play a direct role in encouraging regular cancer screening
United Kingdom
-
Fructose slows liver tumors in mice when key sugar-processing gene is missing, may lead to new treatments
United Kingdom